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Alternatively spliced b-neurexins (b-NRXs) and
neuroligins (NLs) are thought to have distinct extra-
cellular binding affinities, potentially providing a
b-NRX/NL synaptic recognition code. We utilized
surface plasmon resonance to measure binding
affinities between all combinations of alternatively
spliced b-NRX 1-3 and NL 1-3 ectodomains. Binding
was observed for all b-NRX/NL pairs. The presence
of the NL1 B splice insertion lowers b-NRX binding
affinity by 2-fold, while b-NRX splice insertion
4 has small effects that do not synergize with NL
splicing. New structures of glycosylated b-NRXs 1
and 2 containing splice insertion 4 reveal that the
insertion forms a new b strand that replaces the
b10 strand, leaving the NL binding site intact. This
helps to explain the limited effect of splice insert 4
on NRX/NL binding affinities. These results provide
new structural insights and quantitative binding
information to help determine whether and how
splice isoform choice plays a role in b-NRX/NL-medi-
ated synaptic recognition.
INTRODUCTION
In vertebrates, with nervous systems comprising billions of
neurons with trillions of connections between them (Cowan
et al., 2000), the construction of functional circuits requires
appropriate specification of a large number of neural connec-
tions. However, the molecular mechanisms underlying this
extraordinary specificity remain unclear. Presynaptic neurexins
(NRXs) bind to postsynaptic neuroligins (NLs) to form complexes
that span the synapse and are thought to play important roles in
synaptic specification (Sudhof, 2008). Both NRX and NL gene
transcripts can be spliced alternatively, yielding diverse ectodo-
mains. It has been suggested that this diversification may
provide a mechanism to help specify either the formation (Chihet al., 2004; Graf et al., 2004; Nam and Chen, 2005; Scheiffele
et al., 2000) or validation (Chubykin et al., 2007; Ko et al.,
2009b; Missler et al., 2003; Varoqueaux et al., 2006) of synaptic
connections. The importance of NRX/NL interactions to neural
function is highlighted by the association of mutations in both
NRX and NL genes with autism spectrum disorders (Garber,
2007; Geschwind and Levitt, 2007; Jamain et al., 2003; Laumon-
nier et al., 2004; Moretti et al., 2006; Sudhof, 2008; Szatmari
et al., 2007; Tabuchi et al., 2007).
Vertebrate genomes encode three NRX genes, each of which
can be transcribed from two alternative promoters, resulting in
the longer a-NRX and the shorter b-NRX forms (Figure 1A)
(Ushkaryov et al., 1992). Both a- and b-NRXs are class I trans-
membrane proteins with C-terminal regions in common, but
with distinct N-terminal ectodomain sequences (Ushkaryov
et al., 1994). The extracellular part of a-NRXs consists of an
a-specific signal peptide, which is removed from the mature
protein, and three repeats, each containing an epidermal growth
factor (EGF)-like domain flanked by two LNS (laminin, neurexin,
sex-hormone-binding globulin) domains (Figure 1A). The shorter
b-NRXs contain their own unique signal peptide followed by a
b-NRX-specific sequence, and a single LNS domain, LNS6.
The membrane proximal LNS 6 ectodomain region, transmem-
brane, and cytoplasmic regions are identical in both a and
b isoforms (Figure 1A). In addition to this diversification of gene
products by promoter choice, both a- and b-NRXs undergo
extensive alternative splicing. a-NRXs have five alternative splice
sites, SS1 through SS5, resulting in thousands of possible
different a-NRX protein isoforms, whereas b-NRXs can be alter-
natively spliced at two sites, SS4 and SS5, resulting in four
different isoforms for b-NRXs 1 and 2 and up to 32 for b-NRX3
which has 16 variants at SS5 (Rowen et al., 2002; Tabuchi and
Sudhof, 2002; Ushkaryov and Sudhof, 1993). The SS5 splice
site is in the ‘‘stalk’’ region that connects the b-NRX LNS domain
to the transmembrane segment, thus the SS4 site is the only
locus of splice form diversification within the LNS domain that
binds NLs. Alternative splicing of b-NRXs results in the presence
or absence of ‘‘insertion sequences.’’ Thus, for b-NRXs 1, 2, and
3, six alternatively spliced LNS domains in total can be
produced: those lacking an insertion at SS4 (referred to here
as the D4 isoform, e.g., b-NRX1D4) and those containing anNeuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc. 61
Figure 1. NRX and NL Alternative Splicing
(A) NRXs are transcribed from two independent promoters for each gene resulting in the longer a-NRXs and shorter b-NRXs. a-NRXs contain three repeats, each
of which consists of an EGF domain flanked by two LNS domains. a-NRX and b-NRXs share the LNS 6 domain, a transmembrane region, and a short cytoplasmic
domain. The arrows indicate the alternative splicing sites in eachmolecule. The amino acid sequences for the insert at splice site 4 of each b-NRX are also shown.
(B) NLs 1, 2, and 3 contain an extracellular domain, which forms homodimers, a stalk region, transmembrane, and cytoplasmic domains. All three NLs undergo
splicing at site A and NL1 only can also be spliced at site B, resulting in 10 different NL variants. The amino acid sequences for the inserts introduced as a result of
splicing are shown.
(C) Structure of a b-NRX1D4/NL1D complex with b-NRX1D4 shown in silver and NL1D in yellow (PDB ID 3B3Q) (Chen et al., 2008). The SS4 insertion point for
b-NRXs is shaded in magenta, the SSA insertion point for NLs is shaded in orange, and the SSB insertion point for NL1 in red.
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Splice Form Effects on b-NRX/NL Binding Affinitiesinsertion sequence at SS4 (referred to as the +4 isoform, e.g.,
b-NRX1+4). These six different b-NRX gene products, including
their splice site positions and insertion sequences (Figure 1A),
are highly conserved across mammalian genomes, suggesting
that the function of the different genes and splice isoforms serve
conserved biological roles (Ullrich et al., 1995; Ushkaryov et al.,
1994). The SS4 insert sequences of b-NRX1 and b-NRX2 differ at
only one amino acid position, but the b-NRX3 SS4 insert differs
more substantially (Figures 1A and S5). Crystallographic studies
of LNS domains from NRXs have revealed a 14-stranded
b-sandwich structure similar to those of serum amyloid P protein
and some lectins (Koehnke et al., 2008b; Rudenko et al., 1999;
Sheckler et al., 2006; Shen et al., 2008).
NLs in vertebrates are encoded by five genes, NL1 to 5,
although NLs 4 and 5 are more distant relatives (Bolliger et al.,
2001). Like their NRX binding partners, each NL is subject to
insertion-type alternative splicing which leads to the production
of diverse ectodomains. All three NLs studied here (NLs 1–3)
contain a splice site at position A, while NL1 alone contains
an additional splice site at position B (Figure 1B). In total, the
gene products of NLs 1 to 3 encompass a set of 10 distinct iso-
forms. The three NL genes show a high level of conservation
between genes and among vertebrate species (Ichtchenko
et al., 1996). Crystallographic and biophysical characterization
of NL proteins show that NLs adopt a homodimeric form similar
to acetylcholinesterase, where a tight dimer interface is formed62 Neuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc.through a four-helix bundle near the C terminus of the
esterase-like domain (Arac et al., 2007; Chen et al., 2008;
Fabrichny et al., 2007; Koehnke et al., 2008a).
A single NL dimer binds two b-NRX molecules in a Ca2+-
dependent manner (Comoletti et al., 2003, 2006; and see below).
As demonstrated by recent structures of b-NRX/NL complexes
(Arac et al., 2007; Chen et al., 2008; Fabrichny et al., 2007),
a calcium ion that shares ligation between b-NRX and NL part-
ners plays an important role in complex formation. Although
several crystal structures for b-NRX/NL complexes are available
(Arac et al., 2007; Chen et al., 2008; Fabrichny et al., 2007), each
structure represents a complex between the D-isoforms of both
binding partners. Therefore, while the positions of the splice
insertion sites relative to the b-NRX/NL interface have been
determined (Figure 1C), the structural role of the insertion
sequences remains unclear.
Several recent studies (Boucard et al., 2005; Chih et al., 2006;
Graf et al., 2006; Reissner et al., 2008) investigated the effects of
alternative splicing on b-NRX/NL binding, hemisynapse forma-
tion, and neuronal function in cell culture. Results from these
studies are partly contradictory: Some results indicate that
splicing at site 4 in b-NRX1 and at site B in NL1 jointly regulate
selectivity, but other results fail to support this conclusion.
It was shown that the presence of the 30-residue SS4 insert
in b-NRX1 reduced binding to cells expressing NL1B (NL1
that contains an insert at site B), while maintaining binding to
Neuron
Splice Form Effects on b-NRX/NL Binding Affinitiescells expressing NL1D (NL1 without any insert), or to NL2 (which
lacks a B splice insertion) (Chih et al., 2006). However, results of
a similar assay suggested that alternative splicing had no
discernable effect on the ability of soluble b-NRXs to bind to
NL-expressing cells, although in the same study the authors
found splice-dependent binding differences in pull-down assays
(Boucard et al., 2005). Further, it has been reported that N-linked
glycosylation of the B splice insert is critical for regulation of the
interaction of NL1 with NRX, since mutation of the glycosylation
site in the B insert ablates its reported function in attenuating
NRX1 binding and glutamatergic synapse induction (Chih et al.,
2006; Comoletti et al., 2003). The presence or absence of an
insert at the A site of NLs did not affect binding of NL to b-NRX
in these cell-binding studies (Boucard et al., 2005; Chih et al.,
2006).
Studies of the effect of NRX and NL splice isotype on intermo-
lecular NRX/NL binding interactions have also yielded
contradictory results. A recent study (Comoletti et al., 2006)
used surface plasmon resonance (SPR) measurements to deter-
mine the effect of the SS4 insertion sequence on NL binding.
Results from this SPR study, which reported only relative binding
strengths, suggested that while both the D4 and +4 splice forms
bound NL1D, b-NRX1+4 binding was attenuated. In another
study (Boucard et al., 2005), the authors concluded from pull-
down studies that binding of b-NRX1+4 to NL1B is abolished.
However, analogous pull-down assays performed by Reissner
and colleagues indicate that NL1B is capable of binding to
b-NRX1+4 (Reissner et al., 2008). A structural rationale for the
effects of splice insertion 4 on b-NRX binding to NLs was also
explored in recent crystallographic studies of a bacterially
produced b-NRX1+4 ectodomain (Shen et al., 2008). In this
molecule, residues of the splice insertion form a helix extending
from the connection between b strands 10 and 11. This helix
protrudes from the NL binding face of the protein, adopting
a conformation that would be expected to sterically inhibit NL
binding (Shen et al., 2008). This result has been interpreted as
supportive of the affinity-regulation model for alternative
splicing. In contrast, we have reported based on nuclear
magnetic resonance (NMR) measurements that splice insertion
4 of a bacterially produced b-NRX1+4 is unstructured in solution
(Koehnke et al., 2008b).
To gain understanding of b-NRX/NL interactions, and to
provide a detailed quantitative description of the energetic
effects of alternative splicing, we have used SPR to determine
the kinetic rates (ka, kd) and the binding affinities (KDs) for the
interaction of all pairwise combinations of b-NRXs 1 to 3 and
NLs 1 to 3. Although previous reports have used SPR tomeasure
the relative strength of a small subset of b-NRX/NL interactions,
here we employ a global approach to provide quantitative anal-
ysis of the binding of the two splice isoforms (+4 and D4) of the
LNS domains from each of the three b-NRXs with the 10 splice
isoforms of NLs 1, 2, and 3. Our results show that all NL family
members, whether or not they carry insert A or B, can bind to
all b-NRX isoforms whether they contain or lack splice inser-
tion 4. The presence of insert B in NL1 weakens the binding with
b-NRXs, yet the changes in KD are moderate (<2.4-fold in all
instances). On the other hand, the presence of splice insert
4 weakens binding of b-NRXs 1 and 2 but strengthens bindingof b-NRX3with NLs. NL3 exhibits2- to 250-fold weaker binding
than NL1 or NL2, irrespective of splice isoform.
We interpret these results based on a new structure of
a glycosylated b-NRX3D4 which is nearly identical to nonglyco-
sylated b-NRXs, and two new crystal structures of splice insert-
containing glycosylated b-NRX ectodomains, b-NRX1+4 and
b-NRX2+4. Distinct from the structure of nonglycosylated
b-NRX1+4 (Shen et al., 2008), our new structures show that
the SS4 insertion sequence interacts with glycan and part of the
insertion sequence forms a ‘‘new’’ b strand that replaces the
‘‘old’’ b10 strand in the LNS domain b sandwich. The displaced
b10 strand and another segment of splice insertion 4 form
a new structure that protrudes from the b-NRX face most distal
from the NL binding site, while the NL binding surface remains
largely intact. The position of the new structure formed by
elements from the displaced b10 strand, on a b-NRX face distal
from theNLbinding site, suggests, together with the SPR results,
that insertion sequences at b-NRX SS4 may function in a role
other than to modulate binding affinity for NLs.
RESULTS
All of the 16 proteins used in this work were produced in
a mammalian expression system as detailed in the Experimental
Procedures section (Figure S1). Analytical ultracentrifugation
(AUC) studies show that each NL forms tight constitutive dimers
independent of the presence of splice insertions, and all six
b-NRX isoforms were monomeric regardless of splice isoform
(data not shown), in agreement with prior results (Comoletti
et al., 2003, 2006; Koehnke et al., 2008a, 2008b).
SPR Binding Experiments
SPR binding assays have been used previously to investigate the
binding properties of b-NRX to NL (Arac et al., 2007; Boucard
et al., 2005; Comoletti et al., 2003, 2006). In our experiments
we have optimized the assay design to obtain accurate binding
parameters for each interaction as outlined in Figure 2A and
discussed in the Supplemental Information. Figures 2B–2M,
S2, and S3 show results typical of the SPR binding assays
reported here for the interaction of each of the six b-NRX iso-
forms with each of the 10 NL isoforms. The SPR traces for all
b-NRXs reported here indicate that binding to the immobilized
NLs was specific and concentration dependent. Triplicate injec-
tions at the same b-NRX concentration superimpose with each
other, demonstrating that (1) the assay is reproducible, (2)
nonspecific binding has been eliminated, and (3) the NL surfaces
do not lose binding activity as a result of the regeneration condi-
tions. The experimental binding signals of each of the 60 pairwise
b-NRX/NL interactions, which are illustrated in black, overlay
well with the red traces that represent the fit to a 1:1 binding
model. The complete matrix of binding affinities (Figure 2N and
Table 1) shows a significant spread with KDs for the strongest
binders 0.25 mM compared to the weakest interactions at
60 mM, demonstrating a substantial range in affinities for
b-NRX/NL ectodomain interactions of 250-fold for the set
of proteins tested here. The complete set of ka, kd, and KD values
are listed in Table S1. To help assess the contribution of b-NRX
and NL splice insertion sequences to the affinities of b-NRX/NLNeuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc. 63
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Table 1. Effect of the b-NRX SS4 Insert and NL A/B Inserts on the b-NRX/NL Binding KDs

























NL1D 0.828(2) 0.917(5) 1.02(1) 1.54 (1) 3.77(3) 0.3320(1) 1.00 1.00 1.00 1.86 4.11 0.33
NL2D 0.964(2) 0.7055(8) 0.418(2) 3.520(9) 3.388(7) 0.262(5) 1.00 1.00 1.00 3.65 4.80 0.63
NL3D 8.17(3) 16.48(3) 10.1(3) 23.8(3) 56.8(3) 9.73(1) 1.00 1.00 1.00 2.91 3.45 0.96
NL1A 0.845(3) 1.466(7) 0.782(3) 2.096(4) 3.317(7) 0.2460(4) 1.02 1.60 0.77 2.53 3.62 0.24
NL1B 1.16 (1) 2.21(1) 1.10(8) 2.754(8) 5.48(2) 0.3650(8) 1.40 2.41 1.08 3.33 5.98 0.36
NL1AB 1.21 (6) 2.29 (5) 1.10(7) 2.82(1) 5.66(2) 0.393(1) 1.46 2.50 1.08 3.41 6.17 0.39
NL2A 0.430(5) 0.65 (1) 0.369(8) 3.168(9) 3.013(8) 0.239 (3) 0.45 0.92 0.88 3.29 4.27 0.57
NL3A1 7.45(3) 9.05(8) 6.26(3) 12.0(5) 20.5(1) 4.32(1) 0.91 0.55 0.62 1.47 1.24 0.43
NL3A2 7.15(5) 23(3) 11.2(1) 21.9(1) 42.2(8) 9.50(2) 0.88 1.40 1.11 2.68 2.56 0.94
NL3A1A2 6.57(3) 15.34(9) 10.9(8) 21.0(1) 48(1) 9.39(1) 0.80 0.93 1.08 2.57 2.91 0.93
The left side of the table shows KD values for the interactions of isoforms of NLs 1, 2, and 3 with isoforms of b-NRXs 1, 2, and 3. The bold quadrant
shows the KDs for interactions where both NLs and b-NRXs lack a spice insert (A or B for NLs and SS4 for b-NRXs). The italic quadrant displays the KDs
for NLs that contain inserts A or B with b-NRXs that lack splice insert 4. The underlined quadrant describes the binding of NLs that lack a splice insert
with b-NRXs containing insert 4, and the plain-text quadrant shows the KDs for the interaction of both insert-containing NLs and b-NRXs. The right side
of the table shows all the KD values normalized against the same NL/b-NRX pair that lacks both inserts, which are in the left bold quadrant. The number
in parentheses represents the error of the fit in the last digit.
Neuron
Splice Form Effects on b-NRX/NL Binding Affinitiesinteractions, we calculated fold changes in KD, relative to D-iso-
forms, for each pairwise interaction. The measured KDs for each
splice insert-containing b-NRX/NL complex were normalized
against the KDs for the corresponding insertless b-NRXD4/NLD
complex (Table 1, bold quadrant). Similarly, to isolate the effects
of splice inserts for b-NRXs (Table S2) or NLs (Table S3), we
normalized KDs against those measured for the corresponding
complex with D-isoform b-NRXs or NLs, respectively.
NL3 Binds b-NRXs Weakly Compared to NL1 and NL2
As can be seen in Figure 2N and Table 1, the strengths of b-NRX/
NL interactions vary somewhat depending on b-NRX subtype
(e.g., NL1D/b-NRXD4 ranges in KD from 0.83 to 1.02 mM), but
the most significant differences are associated with NL subtype.
Whereas interactions of all three b-NRXD subtypes are on the
order of 1 mM KD for NL1 and NL2, interactions with NL3 are at
least an order of magnitude weaker. Figure 2N shows that the
10-fold lesser strength of b-NRX interaction with NL3 is gener-
ally preserved in character irrespective of the splice isoform of
either binding partner. Thus, for interactions between NLDs
and b-NRX+4s (Table 1, underlined quadrant), or interactions
of insert-containing NLs with either b-NRXD4s (Table 1, italicFigure 2. SPR Binding Analysis of b-NRXs 1 to 3 Splice Variants to NL
(A) In the SPR binding assay, NL was immobilized to the sensor chip surface (ligan
(analyte). Two molecules of b-NRX bind to each dimeric NL.
(B–M) b-NRXD4 isoforms binding over sensor chip surfaces immobilized with NL
the exception of panels (B) and (C), where the highest concentration tested was
a 1:1model with a step to account formass transport. The KDs, alongwith fold-cha
in Table S1.
(N) KD values determined by SPR binding analysis for the interaction of the two iso
lacking splice inserts A and for NL1 splice insert B. The values for this plot are lis
(O) The KD values of b-NRX+4 interacting with a given NL, normalized against the
binding to a certain NL compared to the binding of b-NRXD4 are shown in Table
(P) A plot of the association rates (ka) and a plot of the dissociation rates (kd) (Q)
association and dissociation rates were used to calculate the KDs in (N) using thquadrant) or b-NRX+4s (Table 1, plain-text quadrant), the most
significant contributor to differential affinity is the NL subtype,
as NL3 binds to identical b-NRXs with 4- to 40-fold reduced
affinity compared to NL1 or NL2. Unlike the binding differences
observed for NLs with respect to subtype, the three D-isoform
b-NRX subtypes yield affinities that varied by less than 2.3-fold
for each of the NLDs and less than 3.2-fold for interactions
with each insert-containing NL.
Splice Insert 4 Weakens b-NRX1 and -2 Binding,
but Strengthens b-NRX3 Binding to NLs
Figure 2O shows that the presence of the SS4 insert in
b-NRX1+4 led to KDs for binding to NL that were 2- to 7-fold
higher than for interactions with the b-NRX1D4 variant, demon-
strating that the SS4 insert exhibits an inhibitory effect on
b-NRX1/NL interactions. Similarly, for b-NRX2+4 KDs are
increased between 1.8- and 4.8-fold from those for b-NRX2D4
(Figure 2O and Table S2). Notably, the strength of interaction is
decreased for the +4 isoforms of b-NRXs 1 and 2 for all NLs,
irrespective of the NL subtype or splice form. These findings
are consistent with the results recently reported by Reissner
and colleagues (Reissner et al., 2008), where both isoforms ofs 1 to 3 Isoforms
d) and increasing concentrations of b-NRX were injected in the solution phase
isoforms 1D, 1A, 1B, and 1AB at a concentration range of 8.0 to 0.039 mMwith
4 mM. Black traces show the experimental data and red traces show the fit to
nge analyses, are listed in Tables 1, S2, and S3, and the kinetic rates are shown
forms of each b-NRX 1, 2, and 3, with the 10 different NL isoforms, containing or
ted in Table 1.
KDs of the same NL binding to b-NRXD4. The fold changes for each b-NRX+4
S2.
for b-NRX/NL interactions. The values in this plot are shown in Table S1. The
e relationship KD = kd/ka.
Neuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc. 65
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smaller extent if the SS4 insert was present.
In contrast to the uniform inhibition of NL interaction observed
for b-NRXs 1 or 2 when the SS4 insert was included, the effect on
NL binding affinity was opposite for b-NRX3 (Figure 2O). The
b-NRX3+4 isoform exhibited greater affinity for all NLs than
b-NRX3D4, with KDs for b-NRX3+4/NL interactions 0.3 to 0.9
of the corresponding b-NRX3D4/NL interactions. Notably,
whereas the SS4 insertion sequences are identical except for
one conserved substitution between b-NRX1 and b-NRX2, the
b-NRX3 SS4 insert differs more substantially with 14 amino
acid substitutions (Figures 1A and S5). These differences are
likely to underlie the different effects of the SS4 insert in
b-NRX3. Kinetic analysis of these SPR data revealed that the
dissociation rates for complexes involving b-NRX3+4 were
slower than for b-NRX3D4, leading to more stable interactions
(Figures 2P and 2Q and Table S1).
NL Splice Isoform Choice Gives Rise to Relatively Small
Changes in Affinity for b-NRXs
To gain a better understandingof the effects of NL splice inserts A
andBon thebindingaffinitiesof interactionswithb-NRXs, theKDs
for all b-NRX/NL interactions were normalized against the KDs of
the same b-NRX binding to the corresponding NLD (Table S3).
The presence of the B insertion sequence in NL1 increased the
KDs for all the b-NRXs tested, indicating that the inhibitory effect
of the B insert is maintained for all b-NRX family members,
regardless of the presence of the SS4. The relative changes in
KD for each b-NRX, compared to the KD for NL1D, were 2.4-
fold or less, providing further support for the idea that, although
the presence of the B insert can lead to weaker interactions,
NL1B can still maintain strong binding to each of the b-NRXs,
even in the presence of the SS4 insert.
Inclusion of the A insert sequence in NL1 also gave rise to small
effects, leading toKDs forb-NRXs thatwere0.7 to 1.6 of the cor-
responding KDs for NL1D. NL2A had slightly increased affinities
for all b-NRXs, with KDs 0.4 to 0.9 of the corresponding KDs for
NL2D. NL3, all isoforms of which bind b-NRXs more weakly than
NL1 andNL2, has insert sequences A1 and A2, which can alterna-
tively be included together or separately at the A splice insertion
site. Inclusion of the A1 insertion led to enhancement of b-NRX
binding (KD changes 0.4–0.9); inclusion of A2 led to changes of
affinity that depended on the b-NRX partner (KD changes 0.7
to 1.4). Inclusion of the concatenated A1A2 insert also yielded
asmall rangeofchanges inKD relative toNL3D (0.9 to1.1). These
lesser effects of A inserts as compared to the B insert on binding
affinity are consistent with the close proximity of the NL1 B inser-
tion site to the b-NRXbinding surface and thedistal nature of theA
insertion site, which is31 A˚ from the nearest b-NRX atom in the
complex crystal structures (Figure 1C) (Arac et al., 2007; Chen
et al., 2008; Fabrichny et al., 2007).
Affinity Effects of NL and b-NRX Splice Insertions
Are Largely Independent of One Another
The SPR measurements reported here show that the b-NRX1
SS4 insert lessens affinity for NLs in all cases (1.6- to 7.4-fold
increase in KD; Table S2), and similarly the NL1 B insert weakens
binding to all b-NRXs tested (1.1- to 2.4-fold increase in KD;66 Neuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc.Table S3). If the inhibition of binding arose from interference
between the NL1 B insert and the b-NRX SS4 insert, as has
been suggested (Boucard et al., 2005; Chih et al., 2006;
Comoletti et al., 2006), effects of splice insert inclusion in one
binding partner would be expected to be larger when the other
binding partner contained an insertion sequence. However,
results from our SPR experiments show that the binding inhibi-
tion, which results from inclusion of an insertion sequence, is
similar whether or not the binding partner also has an insertion
sequence. The inclusion of the SS4 insert in b-NRX1 increases
the KD by 1.9-fold for NL1D as compared to 2.3-fold increases
for NL1B and NL1AB (Table S2). On the other hand, for b-NRX2,
whose SS4 insert is nearly identical to that of b-NRX1, inclusion
of the SS4 insert leads to a 4.1-fold increase in the KD for inter-
action with NL1D, but only 2.5-fold for NL1B and NL1AB
(Table S2). These results demonstrate that binding inhibition by
the b-NRX and NL insertion sequences are independent of
whether the interacting partner contains an insertion sequence.
Coprecipitation and AUC Experiments Are Consistent
with Results from SPR
Pull-down experiments reported by Boucard et al. showed that
only NL1 isoforms lacking splice insertion B could be precipi-
tated by immobilized b-NRX1+4, implying that the combination
of B and SS4 inserts inhibited detectable binding (Boucard
et al., 2005). However, in the same work, when the orientation
of this experiment was reversed such that the NLs were immobi-
lized, binding to b-NRX1+4 was observed independent of the
presence of the NL1 B insert (Boucard et al., 2005). These results
are in apparent disagreement, and therefore we sought other
experimental means to determine whether b-NRX1+4 and
NL1B can form tight complexes as suggested by the SPR exper-
iments presented here.
We performed coprecipitation experiments in which we
coupled each of the four NL1 isoforms, which contained
C-terminal 8xHis affinity tags, to nickel-nitrilotriacetic acid
(Ni-NTA) beads and incubated these with an excess of either
b-NRX1D4 or b-NRX1+4. After washing, the protein retained
on the beads was analyzed by SDS-PAGE (Figure S4A). These
results are consistent with the SPR data showing that, irrespec-
tive of the splice form of either binding partner, b-NRX1 and NL1
can associate to form complexes.
We also performed sedimentation equilibrium analytical ultra-
centrifugation experiments on stoichiometric mixtures of
b-NRX1D4 or b-NRX1+4 and NL1D or NL1B (Figure S4B). Each
of these AUC experiments, fit with a 1:1 (one NL dimer:two
b-NRX molecules) binding model, revealed the formation of tight
complexes with micromolar affinities, in agreement with the SPR
measurements reported here (Table S4).
Splice Insertion 4 Mediates b-NRX Strand Displacement
with Minimal Changes to NL Binding Site
The structure of b-NRX1+4 was determined by molecular
replacement using the structure of b-NRX1D4 (Protein Data
Bank [PDB] ID 3BOD) as a search model. The b-NRX1+4 struc-
ture, refined at 2.7 A˚ resolution, contains two molecules in the
C2 asymmetric unit, each of which includes residues 86 to 197
and 210 to 288. The structure of b-NRX2+4 was determined by
Figure 3. Structural Rearrangements Take Place
to Accommodate the Splice Insert 4
(A) Superposition of the b-NRX1D4 structure (PDB ID
3BOD) in silver and the b-NRX1+4 structure in cyan. The
SS4 insert is highlighted in magenta.
(B) Superposition of the b-NRX2D4 structure (PDB ID
3BOP) in silver and the b-NRX2+4 structure in cyan. The
SS4 insert is highlighted in magenta.
(C) Superposition of the b-NRX1D4 structure (PDB ID
3BOD) in silver and the glycosylated b-NRX3D4 structure
in green.
(D) Superposition of the new b-NRX1+4 structure in cyan
with the nonglycosylated b-NRX1+4 structure (PDB ID
2R1B) (Shen et al., 2008) in yellow. The SS4 is shown in
red in both structures, highlighting identical sequences
adopting completely different secondary structures.
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3BOP) as the search model. The final structure, refined at 2.3 A˚,
has one molecule in the asymmetric unit including residues 88
to 197 and 214 to 290. The root mean square deviation (RMSD)
between b-NRX1D4 and b-NRX1+4 is 0.97 A˚ for 170 Ca atom
pairs, and the RMSD between b-NRX2D4 and b-NRX2+4 is
1.02 A˚ for 165 Ca atom pairs (Figures 3A and 3B). The structures
of b-NRX1+4 and b-NRX2+4 are highly similar to each other, with
anRMSDof 0.67 A˚ for 189Caatompairs, as expected fromahigh
sequence similarity between the two b-NRXs.
Structural Rearrangements Take Place
to Accommodate the SS4 Insert
Theoverall folds of both b-NRX1+4 and b-NRX2+4consist of 14 b
strands arranged in two curved b sheets, one a helix, and a 310
helix, similar to those of previously determined structures of
b-NRX LNS domains (Koehnke et al., 2008b; Rudenko et al.,
1999; Shen et al., 2008) and to the glycosylated b-NRX3D4
structure we report here (see below). Despite conservation in
the core fold, there are significant structural rearrangements to
accommodate the 30-residue SS4 insertion sequence. In the
b-NRX1+4 and b-NRX2+4 structures, the segment that forms
theb10 strand in theD4 isoformstructures is displaced and forms
an extension of the b9 strand/b9-b10 loop (Figures 3A, 3B, andNeuroS5A). Residues 195 to 200 (b-NRX1+4
numbering for clarity), which form part of the
b10 strand in the D4 isoform structures, are
disordered in the +4 isoform structures. A
segment from the SS4 insert itself forms
a ‘‘new’’ b10 strand at the edge of the convex
sheet, as can be seen unambiguously in simu-
lated annealing omit maps calculated with resi-
dues from the SS4 insert omitted (Figure S6A).
The first nine and 13 residues of the SS4 insert
of the b-NRX 1+4 and 2+4 structures, respec-
tively, are disordered, indicating a high degree
of structural mobility in this region.
A detailed analysis of the ‘‘new’’ b10 strand of
the +4 isoform in comparison with the ‘‘old’’ b10
strand in D4 isoform structures reveals thatalthough the amino acid composition of the two strands is
different, the hydrophobicity and polarity of residues in corre-
sponding positions are retained to some extent (Figures S5B
and S6B). For example, Val222 of the new b10 strand aligns with
the position of Val194 in b-NRX1D4, Val223 aligns with Ile195,
Asp224 with Glu196, and Trp226 with Tyr198. Upon SS4 inser-
tion-induced structural rearrangement, a new hydrophobic
cluster is formed at the N-terminal extremity of the ‘‘new’’ b10
strand in both of the b-NRX1+4 and b-NRX2+4 structures, which
may stabilize the new fold. This cluster is composed of highly
conserved residues, some of which were already in place before
the strand replacement (Tyr173 and Val175 from the b8 strand),
and the remaining of which were positioned to be part of this
structure due to strand replacement (Trp192, Pro193, andVal194
from the ‘‘old’’ b10 strand, and Ile215, Pro216, and Tyr217 from
the insert itself) (Figure S7). The strand replacement also places
the side chain of Arg218 from the ‘‘new’’ b10 strand in a position
to form a salt bridge with Asp190, which may provide additional
stability to the new structure (Figure S7).
Structural Effects of Glycosylation
To assess the structural effects of glycosylation independent
of the SS4 insertion, we also determined the structure of
glycosylated b-NRX3D4 at 2.0 A˚ resolution. The structure isn 67, 61–74, July 15, 2010 ª2010 Elsevier Inc. 67
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b-NRX ectodomains, with 0.70 A˚ RMSD between the glycosy-
lated b-NRX3D4 and the nonglycosylated b-NRX1D4 for 174
corresponding Ca atom pairs (Figure 3C). The structure of a gly-
cosylated b-NRX1D4, determined in complex with NL1D (Arac
et al., 2007), also reveals a high level of similarity to the non-
glycosylated b-NRX1D4 (Koehnke et al., 2008b) with an RMSD
of 0.62 A˚ for all Ca atom pairs. Therefore, it can be concluded
that glycosylation does not induce significant structural rear-
rangements in b-NRXs lacking the splice insertion 4.
In b-NRXs containing the splice insertion 4, however, N-glyco-
sylation at a conserved asparagine residue (Asn184 in b-NRX1,
Asn186 in b-NRX2, and Asn182 in b-NRX3) partially accounts
for stabilization of the ordered part of the SS4 insert. In both of
the new b-NRX1+4 and b-NRX2+4 structures, amannosemoiety
linked to a N-acetyl-D-glucosamine (GlcNAG), which is cova-
lently attached to Asn184, stacks against the indole ring of
Trp226 from the SS4 insert. In the glycosylated b-NRX3D4 struc-
ture, Tyr196 (equivalent to Tyr198 in b-NRX1) makes similar,
although less extensive, van der Waals interactions with the
mannose moiety of the carbohydrate chain covalently attached
to Asn182 (Asn184 in b-NRX1) (Figure S6B). Because Trp226
makes more extensive hydrophobic interactions with the
mannose than Tyr196 does, the presence of a tryptophan
residue in this position may be more energetically favorable
than a tyrosine residue, when both residues are available in the
presence of the SS4 insert.Ca2+ Binding in the Splice Insert 4 Containing b-NRX
Structures
Due to the presence of a calcium chelator, citrate, and low pH in-
the crystallization solution, no bound Ca2+ ions were seen in the
b-NRX1+4 structure. Our analysis of Ca2+ binding is therefore
based on the b-NRX2+4 structure. For convenience in com-
paring with the b-NRX1D4/NL1D structures, b-NRX1+4 number-
ings are used.
Electron density is observed for two Ca2+ ions in the b-
NRX2+4 structure, one of which is at the same site seen in previ-
ously reported b-NRX structures (Arac et al., 2007; Chen et al.,
2008; Fabrichny et al., 2007; Koehnke et al., 2008b; Shen
et al., 2008) and in one of the three b-NRX3D4 molecules in the
asymmetric unit of the b-NRX3D4 structure reported here.
In the presence of the SS4 insert, the octahedral coordination
of this Ca2+ ion remains largely unchanged. Side chain oxygen
atoms of Asp137 and Asn238 and main chain carbonyl oxygen
atoms of Val154 and Ile236 serve as ligands, along with two
well-ordered water molecules, water 1 and water 2 (Figure S8A).
These two water molecules are also present in the b-NRX1D4/
NL1D complex structure (Chen et al., 2008). In our previous b-
NRX1D4 structure, only water 1 is present, while the sixth ligand
is fortuitously contributed by the Glu249 side chain from
a symmetry-related molecule (Koehnke et al., 2008b), overlap-
ping the position of water 2 (Figure S8A). In the b-NRX1D4/
NL1D complex structure, water 2 mediates the Ca2+-dependent
interaction between NL1 and b-NRX1D4 by hydrogen bonding to
the main chain carbonyl oxygen of Gln395 and the side chain
carboxyl of Glu397 from NL1 (Figure S8A).68 Neuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc.The second ‘‘new’’ Ca2+ ion in the b-NRX2+4 structure is coor-
dinated by a side chain carboxylate fromGln233, andmain chain
carbonyl oxygen atoms from Asp229 and Gly231 (Figure S8B).
Presumably, this new binding site can only be present in splice
isoforms containing the SS4 insertion sequence, because the
Ca2+ ion is coordinated by residues from the insert. The biolog-
ical relevance of this ‘‘new’’ Ca2+ binding site is unclear. From
a purely structural standpoint, Ca2+ binding at this site is an addi-
tional element that is likely to stabilize the ‘‘new’’ fold, after b10
strand replacement.
DISCUSSION
The results of the systematic b-NRX/NL affinity measurements
presented here show that, among the substantial set of proteins
we studied, all NLs can bind to all b-NRXs, irrespective of the
splice isoform of either partner. As for classical cadherins
(Katsamba et al., 2009), there is no evidence for a ‘‘binary
code’’ which would require that some pairs of NLs and b-NRXs
fail to bind to one another. Rather, although splice isoform choice
alters KDs by as much as a factor of 7.4, binding affinity for all
b-NRX/NL pairs remains within a range likely to be consistent
with productive cell-adhesive interactions. Moreover, the effects
on KDs of the NL and b-NRX splice inserts appear to act indepen-
dently of one another leading to a graded set of affinities. This
finding is in contrast to the results of previous experiments which
suggested that the combination of b-NRX insert 4 and NL1 insert
B collaborate to inhibit binding (Boucard et al., 2005; Chih et al.,
2006), but supports other studies which failed to find such effect
(Graf et al., 2006; Reissner et al., 2008).
Effects of Gene Identity and Splice Inserts on b-NRX/NL
Interaction Affinities
Some affinity effects can be rationalized in light of the atomic-
level structures of b-NRXs, NLs, and complexes between
them. The b-NRX1D4/NL1D complex structures (Arac et al.,
2007; Chen et al., 2008) show that the insert points for both splice
insert B of NL1 and splice insert 4 of b-NRX1 are at the ‘‘edges’’
of the interaction interface (Figure 1C). The presence of splice
inserts at either of these sites could potentially alter b-NRX/NL
interaction, although our measurements indicate that the effects
are modest.
In all cases, irrespective of the subtype or splice isoform of the
b-NRX binding partner, the presence of NL1 insert B reduced
affinity, albeit by only up to a factor of 2.4. On the other hand,
inclusion of the A inserts in NLs had very small effects on affini-
ties, consistent with the distal nature of the A splice site in the
complex structures (Figure 1C) (Arac et al., 2007; Chen et al.,
2008; Fabrichny et al., 2007).
The similar NL binding affinities of the threeD4 isoform b-NRXs
are not surprising since all are expected to bind to NLs via
a conserved canonical interface in which Ca2+ ions are jointly
coordinated between the two proteins (Arac et al., 2007; Chen
et al., 2008; Fabrichny et al., 2007). The presence of splice inser-
tion 4 in b-NRXs has somewhat larger effects thanNL inserts, but
the character of these effects depends on the b-NRX subtype.
The +4 isoforms of b-NRX1 and b-NRX2 have lower affinity for
NLs, irrespective of NL subtype or splice isoform, with KDs
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isoform proteins. By contrast, inclusion of the SS4 insert in
b-NRX3 had the opposite effect, increasing affinity for all NLs,
leading to KDs that were decreased to 90% to 30% of those
for the corresponding NLs with b-NRX3D4. This difference is
consistent with divergence of the b-NRX3 SS4 insert sequence
as compared to those of b-NRXs 1 and 2, which are far more
similar (Figures 1A and S5).
The binding affinities for each b-NRX/NL pair appear to vary by
a maximum of about 7-fold as a consequence of the splice iso-
forms of the component proteins. It is likely that b-NRX/NL
complexes of various splice isoform combination will exist as
either stable or transient complexes in vivo. The single biggest
effect on affinities is NL subtype dependent and is observed
for NL3 where KDs are an order of magnitude or more larger
than for NLs 1 and 2, independent of splice isoform. The single
largest KD we observe is for the complex formed between
NL3D and b-NRX2+4 although all b-NRX splice variants exhibit
reduced affinities to all variants of NL3. Thus, in this case it is
the gene identity of NL rather than the nature of the insertion
that is the primary determinant of variations in binding affinities.
Structural Changes of b-NRXs Induced by SS4
The structural studies presented here provide an explanation of
the effects on NL binding affinity of b-NRX SS4 insertions that is
not evident from earlier structures of nonglycosylated proteins.
Structures of the glycosylated b-NRX1+4 and b-NRX2+4 ecto-
domains each depict nearly identical changes from insertless
b-NRXD4 structures. Most notably, regions from the SS4 inser-
tion sequence displace the b10 strand of the D4 isoform
structure, producing new molecular surfaces along the length
of the LNS domain edge defined by the new b10 strand, but
leaving the NL binding site essentially unaffected.
Recently, Shen and colleagues determined the structure of
a b-NRX1+4 expressed in bacteria (Shen et al., 2008). In their
structure, while the first 15 residues of the SS4 insert are
disordered, the last 15 residues from SS4, 216 to 230, form an
a helix protruding from the LNS domain surface near the NL
binding site in a conformation that would clearly interfere with
NL binding (Figure 3D). The helical configuration of SS4 seen
in this structure may be due to crystal packing, as the SS4 resi-
dues interact with residues from the convex sheet of a neigh-
boring symmetry mate. Indeed, our previous NMR studies of
b-NRX1+4, also produced in bacteria, indicate that the SS4
insertion of the nonglycosylated protein is unstructured in solu-
tion (Koehnke et al., 2008b). The structural data presented
here indicate that b-NRXs, when posttranslationally glycosylated
as they are in vivo, undergo a significant and defined structural
rearrangement to accommodate the SS4 insertion sequence,
in a manner entirely different from that seen previously for
a bacterially expressed b-NRX1+4.
Which of these structures corresponds to a relevant biological
conformation? Several lines of evidence shed light on this
question: Glycosylation clearly favors the strand-displaced
conformation. In vivo, Asn184 (b-NRX1 numbering) should be
constitutively glycosylated, as we found for the mammalian
cell-expressed proteins described here. Further, this site
is conserved in vertebrate b-NRXs, arguing for its functionalimportance. The 30-amino acid SS4 insertion sequence is itself
highly conserved both among NRX1-2 genes and across
species, and this sequence conservation can be at least partly
explained by constraints imposed by the structural requirements
of strand displacement. In particular, as mentioned previously,
the stabilization of the new structures involves many residues
from the SS4 insert itself (residues 215–217 for the hydrophobic
cluster, Arg218 which forms a salt bridge with Asp190, and
residue Trp226 for stacking against the mannose). The most
compelling evidence favoring the strand-displaced conforma-
tion comes from the effect of SS4 inserts on binding to NLs.
The SS4 insert helix of the bacterial b-NRX1+4 structure
protrudes from the b-NRX surface like a stiff arm that would
certainly clash with a bound NL (Figure 3D), suggesting that
binding of the +4 isoform might be completely or significantly in-
hibited, depending on the rigidity and stability of the protruding
helix. However, in early biophysical studies (Koehnke et al.,
2008b), and in the comprehensive SPR binding analyses
reported here, the presence or absence of the SS4 insert makes
only small differences (2- to 7-fold in KD) for b-NRX/NL inter-
actions. This observed binding behavior is consistent with the
glycosylated b-NRX1+4 structures we report, for which super-
positions on the extant b-NRX1D4/NL1D complex structures
(Arac et al., 2007; Chen et al., 2008) reveal no significant clashes,
andmost of the NL binding surface (90% surface area) remains
unchanged from the D4 isoform structures (Figure 4). Moreover,
in accordance with the high structural conservation of the NL
binding surface in the glycosylated b-NRX +4 isoforms we report
(in particular the Ca2+ binding site and the charged residues
Arg109, Arg232, Asp104, and Arg105), the surface electrostatic
potential of the NL binding region is conserved upon SS4 inser-
tion and remains complementary to the NL surface electrostatic
potential pattern (Figure S9).
Possible Conformations of the SS4 Insert in b-NRX/NL
Complexes
The only significant structural difference induced by the pres-
ence of the SS4 insert in the region of the NL interface is localized
at a part of the b10-b11 loop which carries Arg232. Arg232 forms
a salt bridge with Asp387 from NL1 in the b-NRX1D4/NL1D
complex structures (Arac et al., 2007; Chen et al., 2008)
(Figure 4). This salt bridge is one of only two intermolecular ion
pairs within the b-NRX/NL interface, and is the only one in the
immediate vicinity of SS4. Given the immediate proximity of
Arg232 relative to the SS4 insertion sequence, the presence of
SS4 is likely to change the configuration of Arg232 in complexes
with NLs (Figure 4C), which in principle could lead to disruption
of this salt bridge interaction. Clearly, further structural studies
would be needed to determine the atomic details of the actual
conformation of the SS4 insert and the b10-b11 loop in a bona
fide b-NRX+4/NL structure. Nevertheless, the NL region facing
that variable region of b-NRXs forms a large and clearly electro-
negative groove that can accommodate the likely structural
changes arising from the SS4 insertion (Figure 4).
Conformational differences in the Arg232 region, however,
cannot explain theopposite effects onbindingof splice insertions
in b-NRX3 versus b-NRXs 1 and 2, because this region is well
conserved between them (Figure S5). On the other hand, theNeuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc. 69
Figure 4. Structural Effects of the SS4
Insertion on the NL Binding Site
(A) The b-NRX1+4 structure (cyan) is superposed
onto the b-NRX1D4 (silver) from the b-NRX1D4/
NL1D complex structure (PDB ID 3BIW). The SS4
insert is shown in magenta in the b-NRX1+4 struc-
ture. The electrostatic potential surface is shown
for the NL1 molecule in the complex with the indi-
cated color scale.
(B) Close-up view of the NL binding interface of
b-NRX1D4 with the b-NRX1+4 structure super-
posed. The b-NRX1D4 interface residues with
a buried surface area greater than 5 A˚2 in the
complex structure with NL1 and the same resi-
dues in b-NRX1+4 are represented. The color
coding is the same as in (A).
(C) Close-up view of the part of the b10-b11 loop
that is the most variable upon SS4 insertion.
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Splice Form Effects on b-NRX/NL Binding Affinitiesb-NRX3SS4sequencesdiffer substantially from those ofb-NRX1
and b-NRX2, which are nearly identical (Figure 1A). Although
these SS4 insert residues are localized outside of the NL binding
site, we cannot exclude the possibility that they have a long-
range effect on NL binding affinity, and that they play a role in
the difference observed between b-NRX3 and b-NRXs 1 and 2.
In any case, without atomic-level structural data, we cannot
predict with certainty whether a similar strand displacement
would be induced in b-NRX3 by its SS4 insert. Understand-
ing the molecular basis of the slightly stronger binding of insert-
containing b-NRX3s must await further investigation.
Generality of Splice Insert-Dependent Strand
Displacement
From a purely structural perspective, the strand replacement
observed for the b10 strand in the b-NRX1+4 and b-NRX2+4
structures presented here is favored not only by the different
elements that stabilize the new structure, as described above,
but also by the reduced structural constraints on the b10 strand
and the consequent structural plasticity of that strand. The b10
strand is at the edge of the convex b sheet and its backbone is
thus hydrogen bonded to only one other strand. Moreover, its
side chains are mostly solvent exposed and none of them are
involved in the hydrophobic core of the b sandwich fold. Of
note, a similar b strand replacement has been seen in the piccolo
C2A domain in the presence of a nine-residue splice insert,
which forms a b strand to displace a preexisting b strand at the
edge of b sandwich (Garcia et al., 2004). This type of secondary
structure rearrangement may represent a common mechanism
to realize the effects of alternative splicing.
The crystal structures available for the LNS2 and LNS4
domains of a-NRX (Sheckler et al., 2006; Shen et al., 2008) where
splice insertion sites 2 and 3 (SS2 and SS3) respectively reside,
show that their topology is very similar to the that of the b-NRX
LNS domain. However, SS2 is located on the b8-b9 loop such
that both of the adjacent strands are internal in the b sheet70 Neuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc.topology and are hydrogen bonded to two other strands. This
suggests that a similar strand replacement is unlikely at the
SS2 of the a-NRX LNS2 domain, due to the strong structural
constraints imposed on the two adjacent strands. In the case
of SS3, which is located on the b6-b7 loop of the LNS4 domain,
one of the adjacent strands, the b7 strand, is at the edge of the
concave b sheet, suggesting that strand replacement is
possible, but further studies would be required to determine
the precise structural outcomes of splicing at these sites
(Figure S5C).
Potential Biological Roles for Alternative Splicing
of b-NRXs and NLs
The biophysical measurements presented here define amatrix of
b-NRX/NL ectodomain affinities for all splice isoforms of
b-NRX1, 2, and 3, interacting pairwise with all splice isoforms
of NL1, 2, and 3. We find that all b-NRXs can bind to all NLs,
and while there is a dependence of affinities on splice form, all
affinities are in a range consistent with productive adhesion.
The structures presented here of SS4 insert-containing b-NRXs
provide a structural explanation for the limited effect of SS4
insertion sequences on interaction with NLs, and show that while
the NL binding site remains mainly intact, other regions of the
b-NRX LNS domain are more dramatically altered. Previous
cell-based studies indicated that b-NRX1D4 binds efficiently to
all four NL1 splice isoforms, while b-NRX1+4 binds poorly to iso-
forms of NL1 that include the B insertion (Chih et al., 2006).
However, lesser effects of splice insertion 4 were found in similar
experiments (Boucard et al., 2005; Graf et al., 2006). The prox-
imity in the D-complex structures of NL1 splice site B and
b-NRX1 splice site 4 initially suggested the attractive possibility
that steric hindrance between the inserts might prevent interac-
tion in the corresponding splice insert-containing complex.
However, the extensive set of SPR experiments we present
here reveals maximal splice form-dependent differences in KD
of only 3.4-fold for b-NRX1/NL1 interactions. It is difficult to judge
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a molecular recognition code for b-NRX/NL interactions. Clas-
sical cadherins appear to use graded affinities as an initial
filtering step in cell-sorting processes (Katsamba et al., 2009).
However, it is less likely that NRXs and NLs function in the
same way since they are not required for synapse formation.
Although splice isoform choice has limited effects on the
b-NRX/NL binding, it is possible that alternative splicing of
b-NRXs and NLs may serve a primary biological role other than
to modulate the affinity of their interactions. Notably, recent
work in two laboratories have identified the postsynaptic cell
surface receptor LRRTM2 as a receptor whose binding to
presynaptic b-NRXs depends on the presence of splice insert
4 (de Wit et al., 2009; Ko et al., 2009a), although the molecular
basis of this specificity remains unknown. Comparison of the
strand-displaced b-NRX+4 structures with the insertless
b-NRXD4 structures reveals areas of difference outside of the
NL interacting region. Two regions of b-NRX are substantially
altered by the SS4 insertion: the LNS domain edge defined by
the splice form-specific b10 strand (Figures S6A and S6B), and
a new loop which protrudes from the ‘‘bottom’’ of the LNS
domain that is formed by residues 192 to 200 from the displaced
b10 strand and b9-b10 loop, followed by the N-terminal 17 resi-
dues of the SS4 insert (Figure S7). It is possible that these regions
of insert-dependent structure, rather than or in addition to those
near the NL binding site, may contribute to the biological role of
alternative splicing, for example, to regulate recruitment of
synaptic binding partners other than NLs. Lateral oligomerization
following trans binding, for example of cadherins, ephrins, and
T cell receptors appears to be a widely used mechanism that
is exploited by adhesion molecules, and b-NRX and NL splice
variation could conceivably regulate such a process as well.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Although bacterially produced NRXs have been used in prior biophysical
studies, as described above, appropriate glycosylation is critical to the struc-
ture of the SS4 insert in b-NRXs.We producedmolecules corresponding to the
LNS domains of b-NRXs 1, 2, and 3 for each alternative splice isoform (D4 and
+4). Protein constructs for rat b-NRX1 (residues 86–288), rat b-NRX2 (residues
87–290), and rat b-NRX3 (residues 1094–1297, a-NRX numbering) were
cloned into a proprietary mammalian expression vector obtained from Prof.
Dan Leahy (Johns Hopkins University) to produce proteins with an N-terminal
8xHis-tag. Proteins were expressed in human embryonic kidney (HEK) 293F
cells by transient transfection using Polyfect (QIAGEN) according to the
instructions of the manufacturer. The transfected cells were kept in culture
for an additional 5 days. Secreted b-NRX LNS domains were purified by Ni2+
affinity chromatography followed by ion exchange and gel filtration steps.
Briefly, conditioned medium was collected and buffer adjusted to the final
concentrations of 20 mM Tris (pH 8.0), 500 mM NaCl, 20 mM imidazole, and
3 mM CaCl2. The medium was filtered through a 0.22 mm filter and passed
over HisTrap HP columns (GE Healthcare). The columns were washed with
20 mM Tris (pH 8.0), 500 mM NaCl, 20 mM imidazole, and 3 mM CaCl2, and
the protein was eluted with 250 mM imidazole. Protein concentration in the
eluate was estimated by SDS-PAGE and appropriate amounts of PreScission
protease (GE Healthcare) added to cleave off the 8xHis tag during overnight
dialysis at 4C against 10 mM Tris (pH 8.0), 150 mM NaCl, 3 mM CaCl2, and
1 mM dithiothreitol. Next, proteins were dialyzed at 4C against 20 mM Bis-
Tris (pH 6.0), 100 mM NaCl, and 3 mM CaCl2 and then applied to a Mono S
column (GE Healthcare) equilibrated with the same buffer. Proteins containingthe splice insertion 4 bound to the MonoS column and eluted at approximately
400 mMNaCl. For proteins without the splice insertion 4, the flow through was
passed over a Mono Q column equilibrated with the same buffer and the flow
through collected. Finally, the protein was subjected to size-exclusion chro-
matography (Superdex 200) in 10 mM Tris (pH 8.0), 150 mM NaCl, and
3 mM CaCl2, and concentrated to 10 mg/mL.
Similarly, the cholinesterase-like regions of the rat NL1, 2, and 3 extracellular
domains, NL1 (residues 48–638), NL2 (residues 46–612), and NL3 (residues
42–633), were produced for all possible splice forms. These regions were
fused to the endogenous signal sequences and a C-terminal 8xHis-tag and
cloned into the mammalian expression vector pCEP4 (Invitrogen). Proteins
were overexpressed in HEK293F cells. Conditioned medium that contained
the secreted NLs was collected and buffer adjusted to the final concentrations
of 20 mM Tris (pH 8.0), 500 mM NaCl, 20 mM imidazole, and 3 mM CaCl2. The
medium was filtered through a 0.22 mm filter and passed over HisTrap
HP columns (GE Healthcare). The columns were washed with 20 mM Tris
(pH 8.0), 500 mM NaCl, 20 mM imidazole, and 3 mM CaCl2, and the proteins
were eluted with 250 mM imidazole. The proteins were dialyzed overnight at
4C against a buffer of 20 mM Bis-Tris (pH 6.0), 100 mM NaCl, and 3 mM
CaCl2, and then were applied to aMono S column (GEHealthcare) equilibrated
with the same buffer, with the exception of NLs 3A1 and 3A1A2. All NLs were
present in the flow through of the Mono S column, which along with the NLs
3A1 and 3A1A2 were passed over a Mono Q column equilibrated with the dial-
ysis buffer and eluted using a linear gradient of 200 mM to 350 mM NaCl.
Finally, proteins were subjected to size-exclusion chromatography (Superdex
200) in 10 mM Tris (pH 8.0), 150 mMNaCl, and 3 mMCaCl2, and concentrated
to 10 mg/mL.
SPR Binding Assays
Binding assayswere performed using aBiacore T100 biosensor equippedwith
a Series S NTA chip (GE Healthcare). The instrument was equilibrated in
HEPES-buffered saline (HBS; 10 mM HEPES, pH 7.4, 150 mM NaCl) buffer
at 25C for immobilization of NL to the sensor chip surfaces. NLs were immo-
bilized using a modified amine-coupling chemistry method (Willard and Side-
rovski, 2006) that allows the capture of His-tag-fused proteins to NTAmoieties
followed by amine coupling to the dextran layer of the sensor chip to avoid de-
caying surfaces that are often associated with capture of His-tagged proteins.
A 60 s injection of 500 mM NiSO4 at 20 ml/min was performed over all four flow
cells to load the NTA groups with Ni2+. The carboxyl moieties of the dextran
layer over all four flow cells were activated using a 7 min injection of 50 mM
N-hydroxysuccinimide/200 mM 1-ethyl-3(3-dimethylaminopropyl)-carbodii-
mide hydrochloride (Sigma-Aldrich) at the same flow rate. NLs were diluted
to a concentration of 50 to 25 mg/mL in HBS buffer and injected over indepen-
dent flow cells at 20 ml/min, using short pulses of 6 to 10 s, until a capture level
of 500 RU was achieved in each flow cell. To block any remaining activated
carboxyl groups, 1 M ethanolamine, pH 8.5 (Sigma-Aldrich) was injected over
all surfaces for 4min at 20 ml/min. All four surfaces were post conditioned using
three 10 s-consecutive injections of 350 mM ethylenediaminetetraacetic acid
(EDTA) at 100 ml/min to remove any proteins that were not covalently tethered
to the sensor chip surfaces and any Ni2+ that remained bound to the NTA
groups. In each experiment, three different NLs were immobilized onto flow
cells 1, 3, and 4, leaving flow cell 2 vacant to serve as a reference flow cell.
Kinetic binding analysis was performed in a running buffer of 10mMTris-HCl
pH 7.4, 150 mM NaCl, 3 mM CaCl2, 0.005% Tween 20, and 1 mg/mL bovine
serum albumin at 25C. b-NRX protein stocks were diluted in running buffer
to the highest concentration as described in the figure legends for each exper-
iment. The concentration series for each b-NRX was prepared using a 2-fold
serial dilution in running buffer. During a binding cycle, each sample was in-
jected over all four surfaces for 60 s at a flow rate of 50 ml/min, followed by
a 60 s dissociation phase at the same flow rate, during which running buffer
flows over the bound complexes to collect information about the dissociation
rate of the b-NRX/NL of interest. The surfaces were regenerated using a 10 s
injection of 350 mM EDTA at 100 ml/min, and at the end of each cycle buffer
was injected for 60 s at 50 ml/min. Analyte injections were performed in order
of increasing concentration for each concentration series with each series
tested in triplicate from lowest to highest concentration. For every two binding
cycles of b-NRX, a cycle where buffer was used as the analyte was performed,Neuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc. 71
Table 2. Data Collection and Refinement Statistics
b-NRX1+4 b-NRX2+4 bNRX3D4
Data Collection
Space group C2 C2221 P212121






a, b, g () 90, 103.9, 90 90, 90, 90 90, 90, 90
Resolution (A˚) 2.7 (2.8–2.7) 2.35 (2.43–2.35) 2.00 (2.07–2.00)
Rsym 0.090 (0.325) 0.088 (0.258) 0.120 (0.628)
I/sI 19.7 (2.2) 28.8 (3.6) 14.6 (2.3)
Completeness (%) 98.9 (93.4) 99.6 (92.9) 99.6 (99.5)
Redundancy 3.6 (3.0) 5.8 (3.4) 5.9 (5.4)
Refinement
Resolution (A˚) 20–2.7 20–2.35 20–2.0
Rwork/Rfree 0.206/0.287 0.19/0.252 0.177/0.215
B factors (A˚2)
All atoms 35.8 34.9 30.6
Protein 35.7 34.6 28.7
Ca2+ N/A 42.4 61.8
Water 37.0 37.7 37.0
R.m.s. deviations
Bond lengths (A˚) 0.008 0.013 0.009
Bond angles () 1.234 1.555 1.196




















Rfree = Rwork calculated using 5% of the reflection data chosen
randomly and omitted from the start of refinement.
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Splice Form Effects on b-NRX/NL Binding Affinitieswhich together with the signal from the vacant surface, allows for double refer-
encing of the binding responses (Myszka, 1999) to remove such artifacts as
instrument noise and drift. At the beginning of each experiment, 10 additional
binding cycles utilizing buffer as the analyte were performed allowing for
thermal equilibration of the instrument. These binding cycles were removed
from the analysis. The data were processed and analyzed using Scrubber
2.0 (BioLogic Software, Pty., Campbell, Australia). The binding data were fit
to a 1:1 binding model with a step to account for mass transport to extrapolate
ka and kd. The equilibrium binding constant KD was calculated based on the
relationship KD = kd/ka. In each panel the data are depicted in black and the
fit to the model is shown in red.
Coprecipitation Experiments
For each NL, 50 mg protein was immobilized to 100 ml of Ni-NTA resin
(QIAGEN). The resin was then washed with 4 mL of wash buffer (10 mM Tris
pH 7.4, 150 mM NaCl, 3 mM CaCl2), followed by incubation with 1 mL wash
buffer containing 20 mg b-NRX. The resin was then again washed with 4 mL
of wash buffer, followed by elution with 200 ml 2 mM EDTA. Eluates were
analyzed by SDS-PAGE.
Sedimentation Velocity Measurements
Experiments were performed in a Beckman XL-A/I analytical ultracentrifuge
(Beckman-Coulter) using two-cell centerpieces with tapered walls, 12 mm72 Neuron 67, 61–74, July 15, 2010 ª2010 Elsevier Inc.path length, and sapphire windows. Proteins were dialyzed overnight at 4C
against a dialysis buffer of 10 mM Tris-HCl pH 7.4, 100 mM NaCl, 3 mM
CaCl2. NL1 proteins were used at concentrations of 5 mM dimer, alone or in
the presence of 5, 10, and 20 mM b-NRX1D4 or b-NRX 1+4. All measurements
were recorded at 45,000 rpm at 25C, using interference at 660 nm at 3-minute
intervals between each scan, collecting a total of 340 scans for each sample.
Solvent density, solvent viscosity, and protein v-bar were determined using the
program SednTerp (Alliance Protein Laboratories). Data analysis was per-
formed using SedFit obtained from the National Institute of Bioimaging and
Bioengineering, National Institutes of Health (https://sedfitsedphat.nibib.nih.
gov/software/default.aspx).Crystallization, Data Collection, and Crystallographic Analysis
Crystals of rat b-NRX1+4 were obtained in 26%PEG1000, 0.2 M Li2SO4, 0.1M
phosphate-citrate, pH 4.9. The crystals were cryoprotected with the mother
liquor supplemented with 25% glycerol before flash cooling in liquid nitrogen.
These crystals belong to space group C2 with cell dimensions a = 85.8 A˚,
b = 59.8 A˚, c = 105.7 A˚, b = 103.9. Crystals of rat b-NRX2+4 were obtained
in 22% PEG3350, 0.35 M CaCl2, and 1 mM glutathione/glutathione disulfide.
The crystals were cryoprotected for freezing in liquid nitrogen in mother liquor
supplemented with 35% PEG400. These crystals belonged to space group
C2221 with a = 51.7 A˚, b = 102.1 A˚, and c = 78.5 A˚. Crystals of rat
b-NRX3D4 were obtained in 27% PEG3350, 0.2 M Li2SO4, and 0.1 M NaAc,
pH 5. The crystals were cryoprotected with the mother liquor supplemented
with 25% glycerol before flash cooling in liquid nitrogen. These crystals
belong to space group P212121 with cell dimensions a = 74.7 A˚, b = 83.4 A˚,
and c = 119.8 A˚.
Diffraction data were collected on single crystals at 100K at X4C beam line in
the National Synchrotron Light Source at Brookhaven National Laboratory,
and processed with the HKL program suite (Otwinowski and Minor, 1997).
The structures of b-NRX1+4 and b-NRX2+4were solved bymolecular replace-
ment with PHASER (McCoy et al., 2007) using the structures of b-NRX1D4
(PDB ID code: 3BOD) and b-NRX2D4 (PDB ID code: 3BOP) as the search
models, respectively. Likewise, the structure of b-NRX3D4 was solved by
molecular replacement using the b-NRX1D4 structure as the search model.
Manual rebuilding was done with COOT (Emsley and Cowtan, 2004), and
refinement was performed using REFMAC (Murshudov et al., 1997) imple-
mented in the CCP4 program suite (Collaborative Computational Project
Number 4, 1994). The statistics of data collection and refinement are summa-
rized in Table 2. All molecular graphics figures were generated with the
program Pymol (DeLano Scientific, LLC).ACCESSION NUMBERS
Coordinates have been deposited in the Protein Data Bank with deposition IDs
3MW2 (b-NRX1+4), 3MW3 (b-NRX2+4), and 3MW4 (b-NRX3D4).SUPPLEMENTAL INFORMATION
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